resurg
chikungunya
viru
chikv
form
unpreced
explos
epidem
india
indian
ocean
island
gap
year
major
public
health
concern
current
specif
therapi
avail
treat
chikv
infect
present
studi
vitro
prophylact
therapeut
effect
chloroquin
chikv
replic
vero
cell
investig
inhibitori
effect
observ
chloroquin
administ
preinfect
postinfect
concurr
infect
suggest
chloroquin
prophylact
therapeut
potenti
inhibitori
effect
confirm
perform
plaqu
reduct
neutral
test
prnt
realtim
revers
transcriptas
rt
pcr
analysi
viral
rna
level
cell
viabil
assay
chloroquin
diminish
chikv
infect
dosedepend
manner
effect
concentr
rang
mm
concurr
addit
drug
viru
treatment
cell
prior
infect
drastic
reduc
viru
infect
viral
genom
copi
number
maximum
inhibitori
effect
chloroquin
observ
within
hr
postinfect
hpi
treatment
ineffect
viru
success
pass
earli
stage
infect
mechan
inhibit
viru
activ
chloroquin
involv
impair
endosomalmedi
viru
entri
earli
stage
viru
replic
like
prevent
endocytosi
andor
endosom
acidif
base
compar
evalu
use
ammonium
chlorid
known
lysosomotrop
agent
reemerg
chikungunya
viru
chikv
mani
part
world
associ
sever
clinic
featur
signific
public
health
concern
sinc
chikv
infect
assum
epidem
proport
asia
subsaharan
africa
sever
outbreak
chikv
fever
occur
viru
dissemin
among
popul
sever
island
indian
ocean
comoro
mauritiu
seychel
madagascar
la
reunion
prior
outbreak
india
estim
million
case
report
charel
et
al
mavalankar
et
al
pialoux
et
al
recent
case
chikv
infect
europ
itali
occur
result
travel
infect
area
rezza
et
al
chikv
arthropodborn
viru
alphaviru
genu
togavirida
famili
transmit
primarili
human
aed
aegypti
aed
albopictu
mosquito
like
alphavirus
genom
chikv
consist
linear
positivestrand
rna
molecul
kb
jupp
mcintosh
chikv
caus
acut
ill
character
fever
headach
skin
rash
vomit
myalgia
polyarthralgia
jupp
mcintosh
effect
treatment
licens
vaccin
avail
clinic
manag
chiki
infect
absenc
effect
vaccin
mosquito
control
measur
necessari
seek
effect
antivir
drug
immedi
relief
affect
patient
reduc
viremia
therapeut
applic
small
interf
rna
sirna
inhibit
chikv
replic
achiev
limit
success
chloroquin
effect
antimalari
drug
area
resist
establish
increasingli
chloroquin
appli
clinic
manag
viral
diseas
savarino
et
al
savarino
et
al
chloroquin
effect
antivir
therapeut
clinic
manag
viral
diseas
first
establish
infect
savarino
antivir
effect
chloroquin
sarscov
hiv
type
hepat
b
viru
also
report
kouroumali
koskina
tsai
et
al
vincent
et
al
use
chloroquin
therapeut
infect
current
evalu
clinic
trial
savarino
et
al
light
avail
cost
fact
well
toler
chloroquin
offer
promis
antivir
immunomodulatori
agent
treatment
emerg
viral
diseas
keyaert
et
al
increas
virul
chikv
result
evolutionari
adapt
chikungunya
outbreak
report
schuffeneck
et
al
santhosh
et
al
thu
becom
increasingli
import
develop
effect
therapeut
approach
treatment
chikv
infect
goal
current
studi
evalu
doseand
timedepend
effect
chloroquin
chikv
replic
elucid
mechan
viral
inhibit
vero
cell
vero
cell
obtain
nation
centr
cell
scienc
ncc
pune
india
maintain
eagl
minim
essenti
medium
emem
supplement
g
sodium
bicarbonatel
heatinactiv
fetal
bovin
serum
fb
mm
lglutamin
u
gentamycin
chivk
isol
belong
ec
african
genotyp
use
present
studi
increas
concentr
chloroquin
mm
ad
cultur
vero
cell
determin
maximum
nontox
dose
cell
treat
chloroquin
follow
pretreat
group
drug
ad
cell
hr
prior
infect
concurr
treatment
group
drug
chikv
administ
time
posttreat
group
drug
ad
differ
point
hr
follow
infect
cell
chikv
pretreat
mode
chloroquin
remov
wash
cell
infect
concurr
posttreat
mode
drug
maintain
cultur
supernat
harvest
cell
seed
cm
cell
cultur
flask
densiti
cellsml
cell
per
flask
incub
hr
cell
infect
chikv
multipl
infect
moi
drug
administ
three
differ
treatment
group
hr
pretreat
concurr
treatment
posttreat
hpi
infect
allow
proceed
hr
time
cell
scrape
viru
releas
supernat
freez
thaw
cell
three
time
cell
pellet
remov
centrifug
min
viru
yield
determin
plaqu
assay
cell
seed
cultur
plate
greiner
bioon
solingen
germani
densiti
cell
well
allow
grow
confluenc
medium
discard
cell
monolay
infect
chikv
pfuwel
seed
cell
treat
drug
hr
infect
concurr
infect
hpi
period
hr
allow
viru
adsorpt
cell
overlaid
overlay
medium
contain
methylcellulos
fc
appropri
concentr
drug
hr
overlay
medium
remov
infect
cell
monolay
fix
pbsformaldehyd
viru
plaqu
form
vero
cell
visual
stain
crystal
violet
percent
inhibit
determin
rel
untreat
control
cell
antivir
activ
assess
perform
cell
viabil
assay
cell
infect
chikv
presenc
variou
concentr
ammonium
chlorid
ribavirin
chloroquin
number
viabl
cell
quantifi
hpi
neutral
red
dye
uptak
assay
finter
select
index
test
compound
pretreat
concurr
posttreat
hpi
group
determin
ratio
concentr
test
compound
requir
reduc
cell
viabil
cc
concentr
requir
inhibit
viru
infect
compar
control
cell
ic
vero
cell
monolay
cultur
cm
flask
infect
chikv
moi
confluenc
increas
concentr
drug
mm
ad
treatment
group
pretreat
concurr
posttreat
hpi
infect
allow
proceed
hr
time
ml
cultur
supernat
drawn
treatment
group
triplic
pool
genom
viral
rna
extract
ml
pool
supernat
use
qiaamp
viral
rnamini
kit
qiagen
hilden
germani
accord
manufactur
protocol
total
copi
number
chikv
genom
analyz
sybr
green
ibas
onestep
realtim
quantit
rtpcr
previous
describ
region
envelop
gene
amplifi
use
follow
specif
primer
forward
revers
realtim
rtpcr
perform
use
mx
quantit
pcr
system
stratagen
la
jolla
ca
test
sampl
analyz
follow
optim
rna
standard
use
brilliant
sybr
green
singlestep
qrtpcr
master
mix
stratagen
amplif
melt
curv
analysi
perform
verifi
authent
amplifi
product
accord
specif
melt
temperatur
use
melt
curv
analysi
softwar
system
analysi
rel
cycl
threshold
c
valu
perform
overal
reduct
genom
copi
number
calcul
plot
c
versu
genom
copi
number
subconflu
monolay
vero
cell
plate
infect
chikv
duplic
treat
chloroquin
concentr
mm
increas
period
time
postinfect
hpi
supernat
collect
time
point
viral
load
determin
plaqu
titrat
assess
chikv
growth
kinet
effect
chloroquin
viru
intern
assess
immunofluoresc
test
ift
cultur
vero
cell
infect
chikv
presenc
absenc
drug
infect
allow
proceed
hr
cell
wash
five
time
pb
fix
use
chill
methanol
cell
permeabil
use
detect
intracellular
viru
fix
cell
incub
rabbit
antichikv
hyperimmun
serum
dilut
follow
fitcconjug
antirabbit
igg
sigma
st
loui
mo
cell
wash
observ
use
carlzeiss
aximot
thuringia
germani
microscop
equip
incid
illumin
narrow
band
filter
combin
specif
fitc
mechan
inhibit
chikv
activ
chloroquin
assess
compar
effect
chloroquin
known
lysomotrop
agent
ammonium
chlorid
interfer
earli
stage
infect
standard
antivir
compound
ribavirin
inhibit
viru
replic
late
stage
infect
confluent
monolay
vero
cell
infect
moi
chikv
treat
appropri
concentr
ammonium
chlorid
ribavirin
chloroquin
hr
hr
chikv
infect
case
pretreat
compound
remov
wash
infect
cell
viabil
measur
hpi
neutral
red
dye
uptak
assay
describ
prior
screen
determin
maximum
nontox
dose
chloroquin
vero
cell
concentr
mm
chloroquin
nontox
vero
cell
growth
kinet
chikv
vero
cell
differ
multipl
infect
also
determin
establish
appropri
time
line
harvest
subsequ
analysi
viral
activ
optimum
viru
yield
follow
infect
titer
pfuml
obtain
hpi
determin
antichikv
activ
chloroquin
analyz
viru
yield
vero
cell
treat
drug
compar
untreat
infect
control
cell
substanti
decreas
viral
titer
cell
pretreat
sever
differ
concentr
chloroquin
concurr
treatment
posttreat
hpi
chloroquin
also
inhibit
chikv
infect
higher
concentr
viral
titer
reduc
nearli
mm
chloroquin
indic
log
decreas
viru
yield
treatment
group
result
provid
substanti
evid
antichikv
activ
chloroquin
fig
antichikv
activ
also
evalu
plaqu
reduct
assay
presenc
mm
chloroquin
plaqu
format
inhibit
pretreat
concurr
posttreat
hpi
group
respect
fig
next
evalu
cell
viabil
infect
vero
cell
presenc
differ
concentr
chloroquin
neutral
red
dye
uptak
assay
base
optic
densiti
nm
od
treat
untreat
cell
ic
ic
select
index
calcul
tabl
pretreat
chloroquin
effect
antichikv
strategi
indic
nearli
higher
select
index
pretreat
group
compar
posttreat
group
analyz
viral
genom
copi
number
follow
infect
chikv
use
realtim
rtpcr
viral
rna
isol
cultur
supernat
chloroquinetr
untreat
cell
amplifi
use
genespecif
primer
describ
materi
method
section
inhibit
chikv
activ
chloroquin
evalu
compar
c
valu
obtain
experiment
condit
specif
amplifi
product
analyz
curv
analysi
depict
figur
amplif
curv
reveal
higher
c
valu
pretreat
concurr
posttreat
group
concentr
chloroquin
compar
infect
cell
result
indic
chloroquin
treatment
reduc
viral
rna
load
therebi
inhibit
chikv
replic
c
valu
treatment
group
concentr
chloroquin
shown
tabl
ii
addit
rel
c
valu
also
determin
absolut
valu
genom
copi
number
use
standard
curv
observ
overal
log
reduct
viral
load
dosedepend
manner
fig
determin
whether
chloroquin
inhibit
chikv
intern
analyz
locat
intracellular
viral
antigen
ift
infect
vero
cell
treat
chloroquin
exhibit
lower
level
fluoresc
intens
compar
infect
cell
decreas
fluoresc
intens
dose
depend
fig
compar
infect
cell
chloroquin
pretreat
infect
cell
exhibit
lower
fluoresc
intens
presenc
mm
chloroquin
fluoresc
cell
undetect
indic
near
complet
inhibit
viru
intern
carri
time
cours
analysi
determin
kinet
viral
inhibit
chloroquin
found
antivir
effect
chloroquin
decreas
significantli
drug
ad
later
hpi
fig
addit
chloroquin
earli
stage
viral
infect
hpi
significantli
affect
viral
yield
later
stage
drug
ineffect
suggest
mechan
inhibit
chikv
chloroquin
involv
earli
stage
viru
replic
begin
investig
put
mechan
action
chloroquin
compar
effect
chloroquin
antivir
compound
ribavirin
ammonium
chlorid
ammonium
chlorid
effect
chikv
ad
prior
infect
protect
cell
ad
hpi
base
cell
viabil
fig
contrast
ribavirin
effect
chikv
infect
ad
time
infect
infect
protect
cell
ad
prior
infect
remov
wash
fig
thu
pattern
protect
chloroquin
similar
ammonium
chlorid
pretreat
cell
inhibit
viru
replic
inhibitori
effect
hpi
fig
current
specif
antivir
treatment
chikv
infect
demonstr
chloroquin
effect
antivir
agent
chikv
infect
vero
cell
cultur
thu
demonstr
vitro
prophylact
therapeut
potenti
chloroquin
inhibit
chivk
infect
chloroquin
treatment
significantli
reduc
viru
yield
reduc
plaqu
form
abil
base
plaqu
form
activ
pfu
viru
fig
also
signific
reduct
viral
rna
copi
number
base
realtim
rtpcr
analysi
fig
provid
strong
evid
therapeut
potenti
chloroquin
inhibit
chikv
replic
cell
viabil
assay
chloroquin
treatment
provid
near
complet
protect
vero
cell
chikv
infect
provid
evid
antivir
potenti
drug
previous
chloroquin
suggest
effect
agent
viral
infect
savarino
et
al
data
obtain
current
studi
indic
j
med
virol
doi
realtim
rtpcr
analysi
chivk
genom
copi
number
amplif
plot
fluoresc
vs
cycl
depict
rel
abund
chikv
rna
supernat
infect
cell
treat
mm
chloroquin
specif
amplifi
product
analyz
curv
analysi
amplif
plot
cell
treat
chloroquin
hr
b
concurr
c
hpi
treatment
group
foldreduct
genom
copi
number
calcul
plot
chloroquin
concentr
e
color
figur
view
onlin
issu
avail
wwwintersci
wileycom
chloroquin
effect
novel
ecsa
genotyp
chivk
caus
sever
recent
explos
unpreced
epidem
chloroquin
weak
base
target
acid
vesicl
lead
dysfunct
sever
protein
chloroquin
shown
inhibit
proteas
activ
affect
dna
synthesi
cassel
et
al
howev
result
suggest
antivir
activ
chloroquin
associ
previous
report
activ
sinc
chikv
infect
unaffect
drug
ad
late
stage
viral
infect
thu
case
pretreat
presenc
chloroquin
might
essenti
viral
inhibit
wherea
chloroquin
necessari
least
hpi
significantli
inhibit
viru
yield
addit
chloroquin
hpi
effect
viral
replic
result
suggest
chloroquin
effect
earli
stage
viral
infect
effect
doseand
timedepend
mechan
action
chloroquin
appear
depend
mode
treatment
pretreat
mode
cell
render
refractori
chikv
infec
vincent
et
al
similar
mechan
may
respons
inhibit
chikv
infect
chloroquin
case
alphavirus
like
sindbi
viru
sinv
semilink
forest
viru
sfv
conform
chang
viral
envelop
glycoprotein
subsequ
viral
fusion
mediat
clathrinmedi
endocytosi
target
cell
low
ph
endosom
compart
detulleo
kirchhausen
report
low
endosom
ph
also
requir
chikv
entri
cell
sourisseau
et
al
case
concurr
treatment
posttreat
hpi
rapid
elev
endosom
ph
abrog
virusendosom
fusion
might
primari
mechan
viru
infect
inhibit
chloroquin
kinet
inhibit
base
time
cours
analysi
clearli
impli
antivir
effect
chloroquin
declin
substanti
drug
ad
later
hpi
fig
posttreat
group
addit
chloroquin
earli
stage
hpi
infect
mark
effect
viru
yield
wherea
late
stage
addit
hpi
ineffect
ic
chloroquin
inhibit
chikv
vitro
similar
plasma
concentr
chloroquin
reach
treatment
acut
malaria
charmot
coulaud
thu
chloroquin
might
inhibit
chikv
infect
subsequ
dissemin
effect
chloroquin
intern
chikv
investig
immunofluoresc
analysi
intracellular
viral
antigen
infect
vero
cell
treat
chloroquin
exhibit
markedli
lower
level
fluoresc
intens
compar
infect
cell
effect
dose
depend
complet
inhibit
higher
concentr
chloroquin
fig
result
ift
also
support
find
pretreat
cell
mm
chloroquin
effect
concurr
treatment
posttreat
hpi
effect
lesser
extent
higher
concentr
chloroquin
result
suggest
chloroquin
treatment
prevent
delay
viru
intern
order
gain
understand
mechan
action
chloroquin
compar
effect
chloroquin
wellknown
antivir
compound
ribavirin
ammonium
chlorid
ribavirin
antivir
compound
inhibit
number
virus
includ
chikv
act
late
stage
viral
infect
gilbert
knight
ammonium
chlorid
lysomotrop
agent
block
earli
stage
infect
exampl
endosomemedi
viru
entri
effect
later
stage
infect
cassel
et
al
ammonium
chlorid
effect
chikv
cell
pretreat
hr
retain
antivir
activ
even
remov
prior
infect
howev
administr
ammonium
chlorid
hpi
protect
cell
chikv
infect
fig
contrast
ribavirin
effect
chikv
infect
administ
infect
inhibitori
effect
observ
cell
pretreat
ribavirin
follow
remov
drug
infect
fig
thu
chloroquin
fig
ammonium
chlorid
exhibit
similar
pattern
inhibit
chikv
propag
suggest
chloroquin
might
also
target
earli
stage
chikv
infect
summari
result
current
studi
suggest
chloroquin
inhibit
chikv
infect
vero
cell
though
mechan
involv
earli
stage
infect
fact
chloroquin
exert
antivir
effect
three
mode
treatment
pretreat
concurr
posttreat
suggest
prophylact
therapeut
potenti
chloroquin
block
product
proinflammatori
cytokin
prolifer
monocyt
macrophag
lymphocyt
thu
repres
potenti
drug
treatment
symptom
chikungunya
diseas
sinc
immunopatholog
factor
might
play
import
role
chikv
infect
would
relev
explor
effect
chloroquin
inflammatori
respons
chikv
infect
